Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.730
+0.065 (1.77%)
Aug 28, 2026, 4:48 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 55.21 million as of August 28, 2026. Its market cap has decreased by -38.62% in one year.
Market Cap
55.21M
Enterprise Value
54.47M
Revenue
30.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.73
ChartMarket Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 55.21M, a decrease of -50.06%. That is a compound annual growth rate of -11.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 55.66M | -2.76% |
| Dec 30, 2025 | 57.25M | -45.34% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synektik Spólka Akcyjna | 2.86B |
| Medinice | 671.42M |
| Medicalgorithmics | 284.65M |
| Milton Essex Spólka Akcyjna | 43.56M |
| Nestmedic | 43.15M |
| InventionMed | 21.70M |
| Adiuvo Investments | 7.11M |
| Zortrax | 836.80K |